Pharma Globenewswire

Menkes Disease Market Set to Grow Through 2036 as First Approved Therapy Establishes Standard of Care and Gene Therapy Advances Preclinically

3 September 2026

DelveInsight’s “Menkes Disease Market Insights, Epidemiology, and Market Forecast 2036“ report delivers an in-depth understanding of Menkes disease, historical and forecasted epidemiology, and market trends in the United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan. To know

Uncategorised

GABA Inhibitor Market Poised for Transformation Through 2034 Amid Expanding Therapeutic Opportunities

3 September 2026

Gamma-aminobutyric Acid Inhibitor Market Outlook The global Gamma-aminobutyric Acid (GABA) inhibitor market is positioned for continued evolution as pharmaceutical companies advance targeted therapies, refine treatment strategies, and address significant unmet needs across neurological and other relevant indications. According to DelveInsight’s “Gamma-aminobutyric Acid

Uncategorised

Gene Therapy Market Forecast 2032: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight

3 September 2026

DelveInsight’s Gene Therapy Market report delivers an in-depth understanding of the Gene Therapy market by Vector Type (Viral and Non-Viral), Delivery Type (Ex Vivo and In Vivo), Indication (Neurological, Oncological, Hematological, Ophthalmological, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest

Uncategorised

Treatment-Resistant Depression Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight

2 September 2026

DelveInsight’s “Treatment Resistant Depression Market Insights, Epidemiology and Market Forecast – 2036” report delivers an in-depth understanding of historical and forecasted epidemiology as well as Treatment-Resistant Depression therapeutics market trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom,

Uncategorised

Erectile Dysfunction Market Expected to Witness Significant Growth by 2034, Driven by Therapeutic Innovation and Rising Awareness DelveInsight

2 September 2026

DelveInsight Business Research LLP has published its latest report, “Erectile Dysfunction Market Insights, Epidemiology, and Market Forecast – 2034,” providing a comprehensive evaluation of the erectile dysfunction (ED) landscape across the seven major markets (7MM), including the United States, EU4 (Germany, Spain,

Uncategorised

Herpes Labialis Market Poised for Growth as Innovative Treatments Reshape Care

2 September 2026

DelveInsight’s latest market analysis highlights evolving treatment practices, emerging therapies, rising awareness, and expanding opportunities across the seven major markets. Herpes Labialis Market Overview The herpes labialis market is expected to experience notable transformation through 2032 as disease awareness increases, healthcare spending

Uncategorised

Vascular Malformations Market Set to Expand as Targeted Pipeline Therapies Advance Through 2036 – DelveInsight

1 September 2026

DelveInsight’s “Vascular Malformations Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of Vascular Malformations, historical and forecasted epidemiology, as well as Vascular Malformations market trends in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.

Uncategorised

Tumour Necrosis Factor Ligand Superfamily Member 15 Inhibitor Market Set for Growth as RG6631 Advances Toward Late-Stage Development

1 September 2026

The global Tumour Necrosis Factor Ligand Superfamily Member 15 (TNFSF15) inhibitor market is emerging as a promising segment within the broader inflammatory and autoimmune therapeutics landscape, driven by growing interest in targeted treatment approaches for ulcerative colitis, Crohn’s disease, and metabolic dysfunction-associated

Uncategorised

The Global Otoscope Market Size is projected to grow at a CAGR of 3.98% during the forecast period from 2024 to 2030 | DelveInsight

31 August 2026

DelveInsight’s Otoscope Market Insights, Competitive Landscape and Market Forecast-2030 report provides the current and forecast market analysis, individual leading Otoscope companies’ market shares, challenges, Otoscope Market Drivers, barriers, trends, and key market Otoscope companies in the market. To read more about the

Latest

Menkes Disease Market Set to Grow Through 2036 as First Approved Therapy Establishes Standard of Care and Gene Therapy Advances Preclinically

GABA Inhibitor Market Poised for Transformation Through 2034 Amid Expanding Therapeutic Opportunities

Gene Therapy Market Forecast 2032: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight

Treatment-Resistant Depression Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight

Erectile Dysfunction Market Expected to Witness Significant Growth by 2034, Driven by Therapeutic Innovation and Rising Awareness DelveInsight

Herpes Labialis Market Poised for Growth as Innovative Treatments Reshape Care

Vascular Malformations Market Set to Expand as Targeted Pipeline Therapies Advance Through 2036 – DelveInsight

Tumour Necrosis Factor Ligand Superfamily Member 15 Inhibitor Market Set for Growth as RG6631 Advances Toward Late-Stage Development

The Global Otoscope Market Size is projected to grow at a CAGR of 3.98% during the forecast period from 2024 to 2030 | DelveInsight

Recent Posts

Banner

Newsletter

Authors